Docusign Inc. (NASDAQ:DOCU – Get Free Report) was the recipient of some unusual options trading on Tuesday. Stock traders bought 17,013 call options on the company. This is an increase of approximately 37% compared to the average volume of 12,445 call options.
Analyst Ratings Changes
A number of research analysts have recently commented on the stock. Robert W. Baird cut their price target on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Argus restated a “hold” rating on shares of Docusign in a research note on Monday, September 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Docusign in a report on Wednesday, October 8th. UBS Group dropped their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. Finally, Wall Street Zen raised Docusign from a “hold” rating to a “buy” rating in a research report on Saturday, September 13th. Four equities research analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $86.71.
Docusign Trading Down 0.8%
Insider Transactions at Docusign
In other Docusign news, Director Teresa Briggs sold 365 shares of the company’s stock in a transaction on Friday, November 28th. The stock was sold at an average price of $69.19, for a total value of $25,254.35. Following the transaction, the director owned 8,805 shares of the company’s stock, valued at $609,217.95. This represents a 3.98% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Anna Marrs sold 365 shares of the stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $68.54, for a total value of $25,017.10. Following the completion of the sale, the director owned 11,163 shares in the company, valued at approximately $765,112.02. The trade was a 3.17% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 102,729 shares of company stock valued at $7,707,523. Company insiders own 1.01% of the company’s stock.
Hedge Funds Weigh In On Docusign
Large investors have recently added to or reduced their stakes in the company. Banque Transatlantique SA purchased a new position in shares of Docusign in the 1st quarter worth approximately $26,000. Summit Securities Group LLC acquired a new stake in Docusign in the first quarter valued at approximately $34,000. Rise Advisors LLC grew its holdings in Docusign by 864.6% in the first quarter. Rise Advisors LLC now owns 463 shares of the company’s stock worth $38,000 after purchasing an additional 415 shares during the last quarter. WPG Advisers LLC purchased a new position in Docusign in the first quarter worth $39,000. Finally, Twin Peaks Wealth Advisors LLC acquired a new position in shares of Docusign during the second quarter worth $43,000. 77.64% of the stock is currently owned by institutional investors.
Docusign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More
- Five stocks we like better than Docusign
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Market Momentum: 3 Stocks Poised for Major Breakouts
- Investing in the High PE Growth Stocks
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- Market Cap Calculator: How to Calculate Market Cap
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
